CD4⁺ T cells kill Id⁺ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo

By Lundin Katrin   Screpanti Valentina   Omholt Hilde   Hofgaard Peter   Yagita Hideo   Grandien Alf   Bogen Bjarne  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 12, 2004-12 ,pp. : 1135-1145

Springer Publishing Company

Access to resources Recommend Favorite

Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B

By Kim Hyoung-Ran   Park Hyun-Joo   Park Jeon   Kim Se   Kim Kunhong   Kim Jongsun  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 5, 2004-05 ,pp. : 461-470

Springer Publishing Company

Access to resources Recommend Favorite

Combination of hyperthermia and bortezomib results in additive killing in mantle cell lymphoma cells

By Milani Valeria   Lorenz Monika   Weinkauf Marc   Rieken Malte   Pastore Alessandro   Dreyling Martin   Issels Rolf  

International Journal of Hyperthermia, Vol. 25, Iss. 4, 2009-06 ,pp. : 262-272

Informa Healthcare

Access to resources Recommend Favorite

The Implication of Repair Processes in the Mechanism of DNA Integration by Lymphoma Cells

By Ayad S.R.   Fox Margaret  

International Journal of Radiation Biology, Vol. 15, Iss. 5, 1969-07 ,pp. : 445-455

Informa Healthcare

Access to resources Recommend Favorite

CD20-specific antibody-targeted chemotherapy of non-Hodgkin’s B-cell lymphoma using calicheamicin-conjugated rituximab

By DiJoseph John   Dougher Maureen   Armellino Douglas   Kalyandrug Lyka   Kunz Arthur   Boghaert Erwin   Hamann Philip   Damle Nitin  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. : 1107-1117

Springer Publishing Company

Access to resources Recommend Favorite